Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Budenofalk 2mg/application foam enema
0105020A0BCABAD
|
Budenofalk | Budesonide | Gastro-Intestinal System | 2,259 |
|
Budenofalk 3mg gastro-resistant capsules
0105020A0BCAAAC
|
Budenofalk | Budesonide | Gastro-Intestinal System | 1,772 |
|
Budenofalk 9mg gastro-resistant granules sachets
0105020A0BCACAE
|
Budenofalk | Budesonide | Gastro-Intestinal System | 112 |
|
Budenofalk 4mg suppositories
0105020A0BCADAI
|
Budenofalk | Budesonide | Gastro-Intestinal System | 6 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.